SPINK5

SPINK5

Target · Serine protease inhibitor

SPINK5 Serine peptidase inhibitor Kazal type 5 · LEKTI

SPINK5 (serine peptidase inhibitor Kazal type 5), also known as LEKTI, is a secreted multidomain serine protease inhibitor. It helps protect the skin barrier and mucous epithelia by restraining proteases involved in desquamation and defence. Browse Assay Genie's current range of SPINK5 research reagents below, or read on for the biology behind the target.

Secreted proteinKazal-type protease inhibitorLinked to Netherton syndrome
1064 aa
Protein length
~121 kDa
Molecular weight
5q32
Gene locus
Kazal-type
Protease inhibitor
Target information

What is SPINK5 (serine peptidase inhibitor Kazal type 5)?

SPINK5 is a serine protease inhibitor thought to be important for the anti-inflammatory and antimicrobial protection of mucous epithelia. It also contributes to the integrity and protective barrier function of the skin by regulating the activity of defence-activating and desquamation-involved proteases. Its major target is KLK5, which it inhibits in a pH-dependent manner. It also inhibits KLK7, KLK14, CASP14 and trypsin.

The SPINK5 gene encodes a multidomain inhibitor containing 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed into multiple protein products, which may differ in their activities and specificities. These products may play a role in skin and hair morphogenesis, as well as in protection of mucous epithelia. The mature protein is secreted. Alternative splicing of the gene produces multiple transcript variants, and the gene sits within a gene cluster on chromosome 5.

The protein is also known as LEKTI (and by the aliases VAKTI, LETKI, NETS and NS), and the gene belongs to the HGNC group of Kazal-type serine peptidase inhibitors. Mutations in the SPINK5 gene may result in Netherton syndrome, a disorder characterised by ichthyosis, defective cornification and atopy. This link makes SPINK5 a reference point for studies of epidermal protease balance and barrier function.

Skin barrier biology

SPINK5 regulates desquamation-involved proteases and contributes to the integrity and protective barrier function of the skin.

Netherton syndrome research

Mutations in SPINK5 may result in Netherton syndrome, characterised by ichthyosis, defective cornification and atopy.

Protease regulation studies

SPINK5 inhibits KLK5 in a pH-dependent manner, and also KLK7, KLK14, CASP14 and trypsin, making it a model for protease control.

Mucosal epithelial defence

SPINK5 is probably important for the anti-inflammatory and antimicrobial protection of mucous epithelia.

Background

SPINK5 frequently asked questions

What does SPINK5 do?

SPINK5 is a secreted serine protease inhibitor. It supports the skin's protective barrier by regulating defence-activating and desquamation-involved proteases, and is probably important for protecting mucous epithelia. Its major target is KLK5, inhibited in a pH-dependent manner, and it also inhibits KLK7, KLK14, CASP14 and trypsin.

Why is SPINK5 also called LEKTI, and does it have isoforms?

LEKTI is a widely used alias for SPINK5, alongside VAKTI, LETKI, NETS and NS. The gene encodes a preproprotein that is proteolytically processed into multiple products with potentially distinct activities, and alternative splicing yields multiple transcript variants.

Is SPINK5 linked to disease?

Yes. According to the NCBI Gene summary, mutations in the SPINK5 gene may result in Netherton syndrome, a disorder characterised by ichthyosis, defective cornification and atopy. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other Kazal-type serine peptidase inhibitors in the SPINK family with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NQ38; product specifications from Assay Genie datasheets.

SPINK5 Product listing